| Name | Tutuilamide A |
|---|---|
| Synonyms |
(2S,3S)-N-((2S,5S,8S,11R,12S,15Z,18S,21R)-2-benzyl-15-ethylidene-21-hydroxy-5-((4-hydroxyphenyl)methyl)-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-8-propan-2-yl-10-oxa-1,4,7,14,17-pentazabicyclo(16.3.1)docosan-12-yl)-2-(((2S)-2-(((E)-4-chloro-3-methylbut-3-enoyl)amino)propanoyl)amino)-3-methylpentanamide
(2S,3S)-N-((2S,5S,8S,11R,12S,18S,21R,Z)-2-benzyl-15-ethylidene-21-hydroxy-5-(4-hydroxybenzyl)-8-isopropyl-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentaazabicyclo(16.3.1)docosan-12-yl)-2-((S)-2-((E)-4-chloro-3-methylbut-3-enamido)propanamido)-3-methylpentanamide |
| Description | Tutuilamide A is a potent porcine pancreatic elastase (PPE) inhibitor, with an IC50 of 1.2 nM. Tutuilamide A also inhibits human neutrophil elastase (HNE; IC50=0.73 nM) and kallikrein 7 (KLK7; IC50=5.0 nM)[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1.2 nM (porcine pancreatic elastase), 0.73 nM (human neutrophil elastase), 5.0 nM (kallikrein 7)[1] |
| References |
| Molecular Formula | C51H69ClN8O12 |
|---|---|
| Molecular Weight | 1021.59 |